5-DMN was discovered to block cell cycles in both the G0/G1 and G2/M phases of HCT116 (p53+/+), while in THP-1 and lung cancer cells, 5-DMN induced S- and G2/M phase arrest respectively (6, 8, 15, 31). The gene discussed is TP53; the disease is lung carcinoma.